For almost 30 years, BioPlan has been a leading source of independent strategic information and analysis for the biopharmaceutical and life sciences.
在近三十年的时间里，BioPlan成 为生物制药及生命科学产业领先 的战略性信息及分析的来源
We offer unbiased strategic market and customer information, recommendations, and analysis required by our clients for making more effective business decisions. Information products include custom market studies, strategic analyses and recommendations, databases, quantitative and qualitative market research, published industry reports, white papers, and textbooks.
We provide trusted market expertise, based on the philosophy that long-term partnership, focused on our clients’ success, is the only model.
News and Announcements
MS Biology University of Texas, MBA University of Pittsburgh, has extensive experience in alliance management in China’s bio-pharmaceutical industry; … LEARN MORE
Mr Lupis is a seasoned communicator, editor, and writer who has published hundreds of data-oriented articles across online and print media. An Ivy … LEARN MORE
Eric Langer, President and Managing Partner, has over 20 years experience in biotechnology and life sciences international marketing, management, … LEARN MORE
Dr Faiz Kermani helped establish the "Global Health Education Foundation" (GHEF), a not-for-profit healthcare charity to improve educational resources … LEARN MORE
Dr. Lynn Johnson-Langer has her PhD from Antioch University in management; she graduated Johns Hopkins University, MBA, Business Management; … LEARN MORE
Our Team in the News
Mr. Ronald A. Rader is uniquely qualified, with a B.S. (Microbiology), M.L.S. (Library Science), and 25+ years experience as a biotechnology, pharmaceutical and chemical information specialist and publisher.
Mr Lupis is a seasoned communicator, editor, and writer who has published hundreds of data-oriented articles across online and print media. An Ivy League master’s graduate with professional experience in science, political risk, and emerging market issues, he networks within and around the biopharmaceutical industry, and is an experienced researcher and interviewer. His professional and […]
International Biopharma Spotlight A Society for Industrial Microbiology and BioPlan Associates … LEARN MORE
International Biopharma Spotlight Society for Industrial Microbiology and … LEARN MORE
China Can Be Ignored No Longer: Long-Term Biopharmaceutical Opportunities Based on Near-Term Demonstrated Growth
BioProcess International, March 2019 Vicky (Qing) Xia and E. Langer … View Article
Pharmaceutical Technology, March 2019, Ilene Roizman and E. Langer … View Article
American Pharmaceutical Review, March 2019, Eric Langer … View Article
Genetic Engineering News; October 2018; E. Langer … View Article